.gif?ad=16248&adview=true)
![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Department of Molecular Biology, Princeton University, New Jersey 08544.
Abstract
It has been reported recently that the wild-type p53 gene product can positively regulate the expression of a test gene adjacent to the enhancer-promoter elements of the murine muscle-specific creatine kinase (MCK) gene. This discussion reports the identification of a wild-type p53 protein-specific DNA-binding element located within the p53-responsive region of the MCK enhancer-promoter element. This p53 protein/DNA-binding element has been defined by DNase I footprint analysis, which identified a 50-bp region. This 50-bp sequence was sufficient to confer wild-type p53 responsiveness on a heterologous minimal promoter. The mutant forms of p53 protein are much less capable of stimulating this DNA element. This study has identified the first example of a naturally occurring wild-type p53-specific DNA-binding element that is able to mediate positive regulation of a test gene. The results suggest a biological function in gene regulation for the wild-type p53 protein that is lost or altered in the mutant p53 proteins.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. N. West, R. C. Ribeiro, J. Jenkins, C. Rodriguez-Galindo, B. C. Figueiredo, R. Kriwacki, and G. P. Zambetti Identification of a Novel Germ Line Variant Hotspot Mutant p53-R175L in Pediatric Adrenal Cortical Carcinoma. Cancer Res., May 15, 2006; 66(10): 5056 - 5062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Damania, J. H. Jeong, B. S. Bowser, S. M. DeWire, M. R. Staudt, and D. P. Dittmer Comparison of the Rta/Orf50 Transactivator Proteins of Gamma-2-Herpesviruses J. Virol., May 15, 2004; 78(10): 5491 - 5499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Reczek, E. R. Flores, A. S. Tsay, L. D. Attardi, and T. Jacks Multiple Response Elements and Differential p53 Binding Control Perp Expression During Apoptosis Mol. Cancer Res., December 1, 2003; 1(14): 1048 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-L. Xie, S. Gupta, A. Miele, D. Shiffman, J. L. Stein, G. S. Stein, and A. J. van Wijnen The Tumor Suppressor Interferon Regulatory Factor 1 Interferes with SP1 Activation to Repress the Human CDK2 Promoter J. Biol. Chem., July 11, 2003; 278(29): 26589 - 26596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Daoud, P. J. Munson, W. Reinhold, L. Young, V. V. Prabhu, Q. Yu, J. LaRose, K. W. Kohn, J. N. Weinstein, and Y. Pommier Impact of p53 Knockout and Topotecan Treatment on Gene Expression Profiles in Human Colon Carcinoma Cells: A Pharmacogenomic Study Cancer Res., June 1, 2003; 63(11): 2782 - 2793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Beachy, S. L. Cole, J. F. Cavender, and M. J. Tevethia Regions and Activities of Simian Virus 40 T Antigen That Cooperate with an Activated ras Oncogene in Transforming Primary Rat Embryo Fibroblasts J. Virol., March 7, 2002; 76(7): 3145 - 3157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Ribeiro, F. Sandrini, B. Figueiredo, G. P. Zambetti, E. Michalkiewicz, A. R. Lafferty, L. DeLacerda, M. Rabin, C. Cadwell, G. Sampaio, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma PNAS, July 31, 2001; 98(16): 9330 - 9335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nagashima, M. Shiseki, K. Miura, K. Hagiwara, S. P. Linke, R. Pedeux, X. W. Wang, J. Yokota, K. Riabowol, and C. C. Harris DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53 PNAS, July 24, 2001; (2001) 161151798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhai and L. Comai Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53 Mol. Cell. Biol., August 15, 2000; 20(16): 5930 - 5938. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. C. McKay, F. Chen, C. R. Perumalswami, F. Zhang, and M. Ljungman The Tumor Suppressor p53 Can Both Stimulate and Inhibit Ultraviolet Light-induced Apoptosis Mol. Biol. Cell, August 1, 2000; 11(8): 2543 - 2551. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Gu, C. Flemington, T. Chittenden, and G. P. Zambetti ei24, a p53 Response Gene Involved in Growth Suppression and Apoptosis Mol. Cell. Biol., January 1, 2000; 20(1): 233 - 241. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Ruiz-Lozano, M. L. Hixon, M. W. Wagner, A. I. Flores, S. Ikawa, A. S. Baldwin Jr., K. R. Chien, and A. Gualberto p53 Is a Transcriptional Activator of the Muscle-specific Phosphoglycerate Mutase Gene and Contributesin Vivo to the Control of Its Cardiac Expression Cell Growth Differ., May 1, 1999; 10(5): 295 - 306. [Abstract] [Full Text]
|
|
|
|
|
|
U. P. Kelavkar and K. F. Badr Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: Evidence that 15-lipoxygenase is a mutator gene PNAS, April 13, 1999; 96(8): 4378 - 4383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Lee, A. J. Crowe, and M. C. Barton p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding Mol. Cell. Biol., February 1, 1999; 19(2): 1279 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Song, H. M. Sheppard, A. W. Norman, and X. Liu Mitogen-activated Protein Kinase Is Involved in the Degradation of p53 Protein in the Bryostatin-1-induced Differentiation of the Acute Promyelocytic Leukemia NB4 Cell Line J. Biol. Chem., January 15, 1999; 274(3): 1677 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Qi, Y. Yuan, V. Desai-Yajnik, and H. H. Samuels Regulation of the mdm2 Oncogene by Thyroid Hormone Receptor Mol. Cell. Biol., January 1, 1999; 19(1): 864 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. SCHAFER, A. TRAUZOLD, T. SEBENS, W. DEPPERT, U. R. FOLSCH, and W. E. SCHMIDT p22/PACAP Response Gene 1 (PRG1): A Putative Target Gene for the Tumor Suppressor p53 Ann. N.Y. Acad. Sci., December 11, 1998; 865(1): 27 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Fuchs, V. Adler, T. Buschmann, Z. Yin, X. Wu, S. N. Jones, and Z.'e. Ronai JNK targets p53 ubiquitination and degradation in nonstressed cells Genes & Dev., September 1, 1998; 12(17): 2658 - 2663. [Abstract] [Full Text]
|
|
|
|
|
|
B. E. Sawaya, K. Khalili, W. E. Mercer, L. Denisova, and S. Amini Cooperative Actions of HIV-1 Vpr and p53 Modulate Viral Gene Transcription J. Biol. Chem., August 7, 1998; 273(32): 20052 - 20057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kamijo, J. D. Weber, G. Zambetti, F. Zindy, M. F. Roussel, and C. J. Sherr Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2 PNAS, July 7, 1998; 95(14): 8292 - 8297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Frazier, X. He, J. Wang, Z. Gu, J. L. Cleveland, and G. P. Zambetti Activation of c-myc Gene Expression by Tumor-Derived p53 Mutants Requires a Discrete C-Terminal Domain Mol. Cell. Biol., July 1, 1998; 18(7): 3735 - 3743. [Abstract] [Full Text]
|
|
|
|
|
|
T. Ouchi, A. N. A. Monteiro, A. August, S. A. Aaronson, and H. Hanafusa BRCA1 regulates p53-dependent gene expression PNAS, March 3, 1998; 95(5): 2302 - 2306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ohlsson, N. Kley, H. Werner, and D. LeRoith p53 Regulates Insulin-Like Growth Factor-I (IGF-I) Receptor Expression and IGF-I-Induced Tyrosine Phosphorylation in an Osteosarcoma Cell Line: Interaction between p53 and Sp1 Endocrinology, March 1, 1998; 139(3): 1101 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xiang, Y. Kinoshita, C. M. Knudson, S. J. Korsmeyer, P. A. Schwartzkroin, and R. S. Morrison Bax Involvement in p53-Mediated Neuronal Cell Death J. Neurosci., February 15, 1998; 18(4): 1363 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Lanni and T. Jacks Characterization of the p53-Dependent Postmitotic Checkpoint following Spindle Disruption Mol. Cell. Biol., February 1, 1998; 18(2): 1055 - 1064. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Caputi, V. Esposito, A. Baldi, A. De Luca, C. Dean, G. Signoriello, F. Baldi, and A. Giordano p21waf1/cip1mda-6 Expression in Non-small-cell Lung Cancer: Relationship to Survival Am. J. Respir. Cell Mol. Biol., February 1, 1998; 18(2): 213 - 217. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Mori, F. Kashanchi, and D. Prager Repression of Transcription From the Human T-Cell Leukemia Virus Type I Long Terminal Repeat and Cellular Gene Promoters by Wild-Type p53 Blood, December 15, 1997; 90(12): 4924 - 4932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Thottassery, G. P. Zambetti, K. Arimori, E. G. Schuetz, and J. D. Schuetz p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents PNAS, September 30, 1997; 94(20): 11037 - 11042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Kato, H. Sato, M. Nagayoshi, and Y. Ikawa Upregulation of the Elongation Factor-1alpha Gene by p53 in Association With Death of an Erythroleukemic Cell Line Blood, August 15, 1997; 90(4): 1373 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Thut, J. A. Goodrich, and R. Tjian Repression of p53-mediated transcription by MDM2: a dual mechanism Genes & Dev., August 1, 1997; 11(15): 1974 - 1986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Datta, B. Li, D. Choubey, G. Nallur, and P. Lengyel p202, an Interferon-inducible Modulator of Transcription, Inhibits Transcriptional Activation by the p53 Tumor Suppressor Protein, and a Segment from the p53-binding Protein 1That Binds to p202 Overcomes This Inhibition J. Biol. Chem., November 1, 1996; 271(44): 27544 - 27555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Maheswaran, C Englert, P Bennett, G Heinrich, and D A Haber The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes & Dev., September 1, 1995; 9(17): 2143 - 2156. [Abstract] [PDF]
|
|
|
|
|
|
P Sabbatini, J Lin, A J Levine, and E White Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes & Dev., September 1, 1995; 9(17): 2184 - 2192. [Abstract] [PDF]
|
|
|
|
|
|
M E Ewen, C J Oliver, H K Sluss, S J Miller, and D S Peeper p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest. Genes & Dev., January 15, 1995; 9(2): 204 - 217. [Abstract] [PDF]
|
|
|
|
 |
|
 T Mahdi, A Brizard, C Millet, P Dore, J Tanzer, and A Kitzis In vitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors J. Cell Sci., January 3, 1995; 108(3): 1287 - 1293. [Abstract] [PDF]
|
|
|
|
|
|
Y Barak, E Gottlieb, T Juven-Gershon, and M Oren Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes & Dev., August 1, 1994; 8(15): 1739 - 1749. [Abstract] [PDF]
|
|
|
|
 |
|
 E Speir, R Modali, E. Huang, M. Leon, F Shawl, T Finkel, and S. Epstein Potential role of human cytomegalovirus and p53 interaction in coronary restenosis Science, July 15, 1994; 265(5170): 391 - 394. [Abstract] [PDF]
|
|
|
|
|
|
P R Yew, X Liu, and A J Berk Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes & Dev., January 15, 1994; 8(2): 190 - 202. [Abstract] [PDF]
|
|
|
|
|
|
J Bargonetti, J J Manfredi, X Chen, D R Marshak, and C Prives A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes & Dev., December 1, 1993; 7(12b): 2565 - 2574. [Abstract] [PDF]
|
|
|
|
|
|
Y Wang, M Reed, P Wang, J E Stenger, G Mayr, M E Anderson, J F Schwedes, and P Tegtmeyer p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes & Dev., December 1, 1993; 7(12b): 2575 - 2586. [Abstract] [PDF]
|
|
|
|
|
|
X Chen, G Farmer, H Zhu, R Prywes, and C Prives Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes & Dev., October 1, 1993; 7(10): 1837 - 1849. [Abstract] [PDF]
|
|
|
|
|
|
X Wu, J H Bayle, D Olson, and A J Levine The p53-mdm-2 autoregulatory feedback loop. Genes & Dev., July 1, 1993; 7(7a): 1126 - 1132. [Abstract] [PDF]
|
|
|
|
|
|
M Debbas and E White Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev., April 1, 1993; 7(4): 546 - 554. [Abstract] [PDF]
|
|
|
|
|
|
J Bargonetti, I Reynisdottir, P N Friedman, and C Prives Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes & Dev., October 1, 1992; 6(10): 1886 - 1898. [Abstract] [PDF]
|
|
|
|
|
|
Y. Kwon, B. S. Shin, and I. K. Chung The p53 Tumor Suppressor Stimulates the Catalytic Activity of Human Topoisomerase IIalpha by Enhancing the Rate of ATP Hydrolysis J. Biol. Chem., June 9, 2000; 275(24): 18503 - 18510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Ding, J. R. Whetstine, T. L. Witt, J. D. Schuetz, and L. H. Matherly Repression of Human Reduced Folate Carrier Gene Expression by Wild Type p53 J. Biol. Chem., March 16, 2001; 276(12): 8713 - 8719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nagashima, M. Shiseki, K. Miura, K. Hagiwara, S. P. Linke, R. Pedeux, X. W. Wang, J. Yokota, K. Riabowol, and C. C. Harris DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53 PNAS, August 14, 2001; 98(17): 9671 - 9676. [Abstract] [Full Text] [PDF]
|
|
